Response to letter entitled: Re: Hydrocortisone to reduce dexamethasone-induced neurobehavioral side-effects in children with acute lymphoblastic leukaemia-results of a double-blind, randomised controlled trial with cross-over design

Annelienke M van Hulst; Martha A Grootenhuis; Erica L T van den Akker; Marry M van den Heuvel-Eibrink

doi:10.1016/j.ejca.2023.112980

Response to letter entitled: Re: Hydrocortisone to reduce dexamethasone-induced neurobehavioral side-effects in children with acute lymphoblastic leukaemia-results of a double-blind, randomised controlled trial with cross-over design

Annelienke M van Hulst, Martha A Grootenhuis, Erica L T van den Akker, Marry M van den Heuvel-Eibrink

Onderzoeksoutput: Bijdrage aan tijdschrift › Artikel › peer review

Originele taal-2	Engels
Pagina's (van-tot)	112980
Tijdschrift	European journal of cancer (Oxford, England : 1990)
Volume	191
DOI's	https://doi.org/10.1016/j.ejca.2023.112980
Status	Gepubliceerd - 2023

Toegang tot document

10.1016/j.ejca.2023.112980

Citeer dit

van Hulst, A. M., Grootenhuis, M. A., van den Akker, E. L. T., & van den Heuvel-Eibrink, M. M. (2023). Response to letter entitled: Re: Hydrocortisone to reduce dexamethasone-induced neurobehavioral side-effects in children with acute lymphoblastic leukaemia-results of a double-blind, randomised controlled trial with cross-over design. European journal of cancer (Oxford, England : 1990), 191, 112980. https://doi.org/10.1016/j.ejca.2023.112980

van Hulst, Annelienke M ; Grootenhuis, Martha A ; van den Akker, Erica L T et al. / Response to letter entitled : Re: Hydrocortisone to reduce dexamethasone-induced neurobehavioral side-effects in children with acute lymphoblastic leukaemia-results of a double-blind, randomised controlled trial with cross-over design. In: European journal of cancer (Oxford, England : 1990). 2023 ; Vol. 191. blz. 112980.

@article{57ed8f7465d64eeba011d37405b4029e,

title = "Response to letter entitled: Re: Hydrocortisone to reduce dexamethasone-induced neurobehavioral side-effects in children with acute lymphoblastic leukaemia-results of a double-blind, randomised controlled trial with cross-over design",

keywords = "Child, Humans, Hydrocortisone/therapeutic use, Cross-Over Studies, Precursor Cell Lymphoblastic Leukemia-Lymphoma/drug therapy, Dexamethasone/adverse effects, Double-Blind Method, Drug-Related Side Effects and Adverse Reactions",

author = "\{van Hulst\}, \{Annelienke M\} and Grootenhuis, \{Martha A\} and \{van den Akker\}, \{Erica L T\} and \{van den Heuvel-Eibrink\}, \{Marry M\}",

year = "2023",

doi = "10.1016/j.ejca.2023.112980",

language = "English",

volume = "191",

pages = "112980",

journal = "European journal of cancer (Oxford, England : 1990)",

issn = "0959-8049",

publisher = "Elsevier Ltd.",

}

van Hulst, AM, Grootenhuis, MA, van den Akker, ELT & van den Heuvel-Eibrink, MM 2023, 'Response to letter entitled: Re: Hydrocortisone to reduce dexamethasone-induced neurobehavioral side-effects in children with acute lymphoblastic leukaemia-results of a double-blind, randomised controlled trial with cross-over design', European journal of cancer (Oxford, England : 1990), vol. 191, blz. 112980. https://doi.org/10.1016/j.ejca.2023.112980

Response to letter entitled: Re: Hydrocortisone to reduce dexamethasone-induced neurobehavioral side-effects in children with acute lymphoblastic leukaemia-results of a double-blind, randomised controlled trial with cross-over design. / van Hulst, Annelienke M; Grootenhuis, Martha A; van den Akker, Erica L T et al.
In: European journal of cancer (Oxford, England : 1990), Vol. 191, 2023, blz. 112980.

Onderzoeksoutput: Bijdrage aan tijdschrift › Artikel › peer review

TY - JOUR

T1 - Response to letter entitled

T2 - Re: Hydrocortisone to reduce dexamethasone-induced neurobehavioral side-effects in children with acute lymphoblastic leukaemia-results of a double-blind, randomised controlled trial with cross-over design

AU - van Hulst, Annelienke M

AU - Grootenhuis, Martha A

AU - van den Akker, Erica L T

AU - van den Heuvel-Eibrink, Marry M

PY - 2023

Y1 - 2023

KW - Child

KW - Humans

KW - Hydrocortisone/therapeutic use

KW - Cross-Over Studies

KW - Precursor Cell Lymphoblastic Leukemia-Lymphoma/drug therapy

KW - Dexamethasone/adverse effects

KW - Double-Blind Method

KW - Drug-Related Side Effects and Adverse Reactions

U2 - 10.1016/j.ejca.2023.112980

DO - 10.1016/j.ejca.2023.112980

M3 - Article

C2 - 37574396

SN - 0959-8049

VL - 191

SP - 112980

JO - European journal of cancer (Oxford, England : 1990)

JF - European journal of cancer (Oxford, England : 1990)

ER -

van Hulst AM, Grootenhuis MA, van den Akker ELT, van den Heuvel-Eibrink MM. Response to letter entitled: Re: Hydrocortisone to reduce dexamethasone-induced neurobehavioral side-effects in children with acute lymphoblastic leukaemia-results of a double-blind, randomised controlled trial with cross-over design. European journal of cancer (Oxford, England : 1990). 2023;191:112980. doi: 10.1016/j.ejca.2023.112980